posts category

Press Room

SEOUL, South Korea–The precision medicine and biotechnology company, Macrogen (CEO Kap-Seok Yang, www.macrogen.com) (KOSDAQ: 038290), announced on December 20 that its NGS clinical laboratories in Seoul headquarters and Bundang Precision Medicine Center had officially received CLIA (Clinical Laboratory Improvement Amendments) accreditation, as the first in …

Continue reading

SEOUL, South Korea–Macrogen, Inc. (CEO Kap-Seok Yang, www.macrogen.com) (KOSDAQ: 038290), a precision medicine biotechnology company, announced on August 13 that its two next-generation sequencing (NGS) clinical laboratories, located in its Seoul headquarters and Bundang Precision Medicine Center, respectively, received the College of American Pathologists …

Continue reading

Macrogen Establishes Overseas Corporation in Singapore to Focus on Southeast Asian Market in Earnest – Macrogen establishes ‘Macrogen Asia Pacific’, a Subsidiary in Singapore – Targeting Southeast Asian market…Focus on large-scale genome analysis project SEOUL, South Korea–Macrogen, Inc. (President Ji-young Moon, www.macrogen.com) (KOSDAQ …

Continue reading

CRISPR-Cas9 commercial research tool technology acquired from Broad Institute will be used to build preclinical model animals and target treatment function analysis to further gene treatment research and development Macrogen, Inc. (CEO Ji-young Moon, www.macrogen.com), a precision medicine biotechnology company, announced on April 5 that it …

Continue reading

ROCKVILLE, MD– Macrogen Corp. (www.macrogenlab.com) announces that its Clinical Lab that provides clinical NGS services has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs …

Continue reading